HealthNewsAPI
Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says - CNBC
Overview
Research finds that even short interruptions in GLP-1 treatment for people with Type 2 diabetes are linked to higher risks of heart attack, stroke and death, underscoring the need for continuous therapy. The new study suggesting GLP-1s may also lower breast cancer risk strengthens arguments for maintaining effective incretin therapy when appropriate, but clinicians must balance cardiovascular, metabolic and potential cancer benefits against side effects and individual patient circumstances. Ongoing trials and longer follow-up will be needed to confirm multi-system protective effects and guide decisions about stopping or restarting treatment.
Entities
ORGCNBCORGHealthy Returns
Relationship Graph
Click a connection line between nodes to view confidence and evidence.
Nodes: 10 · Connections: 9
Caused by
Led to
Related to
Same event
Press enter or space to select a node. You can then use the arrow keys to move the node around. Press delete to remove it and escape to cancel.
Press enter or space to select an edge. You can then press delete to remove it or escape to cancel.
Click a connection for evidence · click a node to open it
Select a connection to see why these events are linked.